| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Corpus Luteum | 21 | 2010 | 81 | 2.980 |
Why?
|
| Ovarian Neoplasms | 32 | 2024 | 4849 | 2.550 |
Why?
|
| Endometrial Neoplasms | 18 | 2024 | 1365 | 2.240 |
Why?
|
| Neoplastic Stem Cells | 12 | 2018 | 1350 | 2.050 |
Why?
|
| Uterine Neoplasms | 12 | 2024 | 1420 | 1.670 |
Why?
|
| Cyclins | 12 | 2019 | 594 | 1.390 |
Why?
|
| Cystadenocarcinoma, Serous | 7 | 2024 | 473 | 1.090 |
Why?
|
| Leiomyoma | 6 | 2018 | 636 | 1.000 |
Why?
|
| Carcinoma, Endometrioid | 4 | 2017 | 276 | 0.930 |
Why?
|
| Dinoprost | 11 | 2010 | 138 | 0.830 |
Why?
|
| Oogenesis | 3 | 2014 | 124 | 0.820 |
Why?
|
| Phosphoproteins | 13 | 2015 | 2446 | 0.820 |
Why?
|
| CA-125 Antigen | 6 | 2024 | 276 | 0.820 |
Why?
|
| Luteolysis | 4 | 2008 | 11 | 0.800 |
Why?
|
| Galectin 3 | 1 | 2024 | 240 | 0.790 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 2 | 2024 | 138 | 0.760 |
Why?
|
| Blood Proteins | 2 | 2024 | 1172 | 0.750 |
Why?
|
| Genital Neoplasms, Female | 2 | 2024 | 532 | 0.690 |
Why?
|
| Cell Proliferation | 22 | 2024 | 10432 | 0.650 |
Why?
|
| Proto-Oncogene Proteins c-kit | 4 | 2018 | 727 | 0.640 |
Why?
|
| Signal Transduction | 30 | 2019 | 23416 | 0.620 |
Why?
|
| Carrier Proteins | 12 | 2015 | 4935 | 0.610 |
Why?
|
| Ovary | 7 | 2019 | 959 | 0.610 |
Why?
|
| Apoptosis | 18 | 2020 | 9476 | 0.600 |
Why?
|
| Progesterone | 12 | 2008 | 742 | 0.580 |
Why?
|
| TOR Serine-Threonine Kinases | 6 | 2017 | 2057 | 0.570 |
Why?
|
| Oocytes | 6 | 2012 | 1166 | 0.570 |
Why?
|
| Xenograft Model Antitumor Assays | 12 | 2021 | 3599 | 0.530 |
Why?
|
| Carcinosarcoma | 2 | 2014 | 106 | 0.510 |
Why?
|
| Loss of Heterozygosity | 3 | 2007 | 662 | 0.500 |
Why?
|
| Endometriosis | 4 | 2014 | 857 | 0.500 |
Why?
|
| Caspases | 4 | 2003 | 878 | 0.500 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 2 | 2014 | 194 | 0.490 |
Why?
|
| Cell Line, Tumor | 27 | 2024 | 16967 | 0.480 |
Why?
|
| Leptin | 6 | 2009 | 1595 | 0.470 |
Why?
|
| Mice | 57 | 2024 | 81368 | 0.460 |
Why?
|
| Vitrification | 1 | 2014 | 51 | 0.460 |
Why?
|
| Endometrium | 8 | 2017 | 403 | 0.460 |
Why?
|
| Carboplatin | 3 | 2014 | 793 | 0.460 |
Why?
|
| Dendritic Cells | 4 | 2014 | 2722 | 0.450 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2017 | 693 | 0.450 |
Why?
|
| DNA Repair | 2 | 2024 | 2043 | 0.440 |
Why?
|
| Animals | 89 | 2024 | 168201 | 0.440 |
Why?
|
| Mucin-1 | 1 | 2018 | 538 | 0.440 |
Why?
|
| Female | 125 | 2024 | 392148 | 0.440 |
Why?
|
| Receptor, erbB-2 | 6 | 2020 | 2553 | 0.440 |
Why?
|
| Ovarian Follicle | 3 | 2019 | 244 | 0.430 |
Why?
|
| Glycoproteins | 6 | 2013 | 2200 | 0.420 |
Why?
|
| Gene Expression Regulation, Neoplastic | 15 | 2020 | 8542 | 0.420 |
Why?
|
| Membrane Proteins | 6 | 2024 | 7847 | 0.420 |
Why?
|
| Toll-Like Receptors | 2 | 2013 | 575 | 0.400 |
Why?
|
| Cryopreservation | 2 | 2014 | 728 | 0.380 |
Why?
|
| Teratoma | 1 | 2014 | 404 | 0.380 |
Why?
|
| Oligopeptides | 1 | 2017 | 1185 | 0.380 |
Why?
|
| Mice, SCID | 12 | 2020 | 2625 | 0.370 |
Why?
|
| Morpholines | 2 | 2014 | 581 | 0.370 |
Why?
|
| Keratin-18 | 1 | 2010 | 38 | 0.370 |
Why?
|
| Receptors, Progesterone | 6 | 2016 | 1129 | 0.370 |
Why?
|
| Paclitaxel | 4 | 2015 | 1730 | 0.350 |
Why?
|
| Disease Models, Animal | 10 | 2019 | 18221 | 0.350 |
Why?
|
| Sphingomyelin Phosphodiesterase | 2 | 2008 | 82 | 0.350 |
Why?
|
| Aminopyridines | 1 | 2014 | 573 | 0.340 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2022 | 2020 | 0.340 |
Why?
|
| Receptors, Notch | 1 | 2014 | 743 | 0.340 |
Why?
|
| Peptides | 7 | 2022 | 4354 | 0.340 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2022 | 2821 | 0.330 |
Why?
|
| Galectins | 2 | 2024 | 295 | 0.330 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 894 | 0.330 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2013 | 4341 | 0.320 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2015 | 1250 | 0.320 |
Why?
|
| Antigens, CD | 5 | 2013 | 3998 | 0.320 |
Why?
|
| Carcinoma | 3 | 2023 | 2327 | 0.320 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2014 | 2456 | 0.320 |
Why?
|
| Gene Amplification | 6 | 2020 | 1087 | 0.300 |
Why?
|
| Granulosa Cells | 5 | 2019 | 115 | 0.300 |
Why?
|
| Genes, erbB-1 | 1 | 2008 | 162 | 0.290 |
Why?
|
| Immunohistochemistry | 14 | 2017 | 11069 | 0.290 |
Why?
|
| Epithelial Cells | 3 | 2019 | 3672 | 0.280 |
Why?
|
| Drug Resistance, Neoplasm | 6 | 2024 | 5304 | 0.280 |
Why?
|
| Ovarian Diseases | 1 | 2008 | 136 | 0.280 |
Why?
|
| Hedgehog Proteins | 1 | 2011 | 768 | 0.280 |
Why?
|
| Antineoplastic Agents | 10 | 2023 | 13635 | 0.270 |
Why?
|
| Mice, Inbred NOD | 9 | 2016 | 1827 | 0.270 |
Why?
|
| Cattle | 14 | 2010 | 3841 | 0.260 |
Why?
|
| Cell Cycle | 5 | 2016 | 2930 | 0.260 |
Why?
|
| Growth Inhibitors | 1 | 2007 | 375 | 0.260 |
Why?
|
| Humans | 99 | 2024 | 760617 | 0.260 |
Why?
|
| Vulvar Neoplasms | 1 | 2008 | 263 | 0.260 |
Why?
|
| RNA, Messenger | 12 | 2014 | 12758 | 0.250 |
Why?
|
| Indoles | 4 | 2016 | 1830 | 0.250 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 2222 | 0.250 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2006 | 123 | 0.250 |
Why?
|
| Neoplasm Transplantation | 6 | 2013 | 2010 | 0.250 |
Why?
|
| Cytokines | 6 | 2014 | 7373 | 0.240 |
Why?
|
| Neoplasm, Residual | 1 | 2010 | 1008 | 0.240 |
Why?
|
| Paraffin Embedding | 2 | 2017 | 302 | 0.240 |
Why?
|
| Epigenomics | 1 | 2010 | 942 | 0.240 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2008 | 546 | 0.230 |
Why?
|
| Gene Silencing | 2 | 2007 | 1503 | 0.230 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2016 | 11736 | 0.230 |
Why?
|
| Adenocarcinoma, Clear Cell | 2 | 2005 | 217 | 0.230 |
Why?
|
| Repressor Proteins | 3 | 2022 | 2985 | 0.230 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2024 | 340 | 0.220 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2007 | 655 | 0.220 |
Why?
|
| I-kappa B Proteins | 2 | 2001 | 211 | 0.220 |
Why?
|
| Stem Cells | 4 | 2011 | 3516 | 0.210 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2024 | 1932 | 0.210 |
Why?
|
| Microsatellite Repeats | 2 | 2006 | 783 | 0.210 |
Why?
|
| Losartan | 1 | 2024 | 263 | 0.210 |
Why?
|
| Caspase 3 | 5 | 2010 | 731 | 0.210 |
Why?
|
| Carcinoma in Situ | 1 | 2008 | 791 | 0.210 |
Why?
|
| MicroRNAs | 5 | 2018 | 3805 | 0.210 |
Why?
|
| Pre-Eclampsia | 1 | 2012 | 1230 | 0.200 |
Why?
|
| Sphingomyelins | 1 | 2002 | 105 | 0.200 |
Why?
|
| Tumor Cells, Cultured | 9 | 2020 | 6126 | 0.200 |
Why?
|
| Pyrroles | 3 | 2013 | 1125 | 0.200 |
Why?
|
| Neovascularization, Pathologic | 5 | 2014 | 2644 | 0.200 |
Why?
|
| Fas Ligand Protein | 4 | 2010 | 216 | 0.200 |
Why?
|
| Uterus | 5 | 2014 | 649 | 0.190 |
Why?
|
| Fatty Acids, Omega-3 | 3 | 2018 | 1390 | 0.190 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2016 | 2864 | 0.190 |
Why?
|
| Papillomaviridae | 3 | 2022 | 1117 | 0.190 |
Why?
|
| Tissue Adhesions | 2 | 2012 | 218 | 0.190 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2022 | 2801 | 0.180 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2022 | 340 | 0.180 |
Why?
|
| Glutamine | 1 | 2023 | 576 | 0.180 |
Why?
|
| Transcription Factors | 7 | 2019 | 12116 | 0.180 |
Why?
|
| Cytomegalovirus Infections | 2 | 2022 | 828 | 0.180 |
Why?
|
| Steroids | 2 | 2002 | 929 | 0.170 |
Why?
|
| Myometrium | 2 | 2018 | 174 | 0.170 |
Why?
|
| Adenocarcinoma | 6 | 2014 | 6340 | 0.170 |
Why?
|
| MAP Kinase Signaling System | 3 | 2003 | 1483 | 0.170 |
Why?
|
| Alphapapillomavirus | 1 | 2022 | 218 | 0.160 |
Why?
|
| Ceramides | 3 | 2008 | 200 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2002 | 1242 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 14 | 2019 | 22115 | 0.160 |
Why?
|
| Enzyme Precursors | 1 | 1999 | 170 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2013 | 4512 | 0.160 |
Why?
|
| Neoadjuvant Therapy | 1 | 2010 | 2827 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 2895 | 0.150 |
Why?
|
| Cell Count | 3 | 2014 | 1835 | 0.150 |
Why?
|
| Receptors, Cell Surface | 3 | 2006 | 2802 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 18 | 3 | 2007 | 247 | 0.150 |
Why?
|
| Receptors, Prostaglandin | 5 | 2005 | 53 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2014 | 3492 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 5 | 2017 | 5672 | 0.150 |
Why?
|
| Reactive Oxygen Species | 2 | 2023 | 2137 | 0.150 |
Why?
|
| Gene Expression | 5 | 2015 | 7568 | 0.150 |
Why?
|
| Interferon-gamma | 4 | 2008 | 3145 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2024 | 3800 | 0.150 |
Why?
|
| Reproduction | 2 | 2012 | 645 | 0.150 |
Why?
|
| Membrane Glycoproteins | 3 | 2003 | 3688 | 0.150 |
Why?
|
| Endothelium, Vascular | 3 | 2008 | 4433 | 0.140 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2018 | 302 | 0.140 |
Why?
|
| Clone Cells | 1 | 2020 | 1657 | 0.140 |
Why?
|
| ras Proteins | 2 | 2013 | 1054 | 0.140 |
Why?
|
| RNA, Small Interfering | 5 | 2019 | 3419 | 0.140 |
Why?
|
| Feedback, Physiological | 1 | 2019 | 475 | 0.130 |
Why?
|
| Mice, Knockout | 9 | 2019 | 14389 | 0.130 |
Why?
|
| Mice, Nude | 7 | 2021 | 3605 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2009 | 4020 | 0.130 |
Why?
|
| Celiac Disease | 1 | 2004 | 819 | 0.130 |
Why?
|
| Endometrial Hyperplasia | 1 | 2017 | 97 | 0.130 |
Why?
|
| Tumor Burden | 4 | 2016 | 1892 | 0.130 |
Why?
|
| Cells, Cultured | 12 | 2019 | 18937 | 0.130 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2015 | 2509 | 0.130 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2015 | 717 | 0.130 |
Why?
|
| Cystadenoma, Serous | 1 | 2016 | 100 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 1133 | 0.130 |
Why?
|
| Mediator Complex | 1 | 2015 | 106 | 0.120 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 3 | 2016 | 899 | 0.120 |
Why?
|
| Serpins | 1 | 1997 | 247 | 0.120 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2011 | 9277 | 0.120 |
Why?
|
| Papillomavirus Infections | 2 | 2022 | 1611 | 0.120 |
Why?
|
| Palliative Care | 1 | 2010 | 3592 | 0.120 |
Why?
|
| Gene Expression Profiling | 6 | 2015 | 9417 | 0.120 |
Why?
|
| Stromal Cells | 2 | 2011 | 1329 | 0.120 |
Why?
|
| GPI-Linked Proteins | 1 | 2016 | 469 | 0.120 |
Why?
|
| Cleavage Stage, Ovum | 1 | 2014 | 44 | 0.120 |
Why?
|
| Blotting, Western | 7 | 2014 | 5034 | 0.120 |
Why?
|
| Cell Communication | 2 | 2020 | 1654 | 0.120 |
Why?
|
| Cyclic S-Oxides | 1 | 2014 | 25 | 0.120 |
Why?
|
| Immunoconjugates | 1 | 2022 | 951 | 0.120 |
Why?
|
| Mice, Transgenic | 5 | 2019 | 9529 | 0.110 |
Why?
|
| Organ Specificity | 1 | 2019 | 1964 | 0.110 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2015 | 618 | 0.110 |
Why?
|
| Thiadiazoles | 1 | 2014 | 63 | 0.110 |
Why?
|
| Prognosis | 9 | 2024 | 29600 | 0.110 |
Why?
|
| Adrenomedullin | 1 | 2013 | 85 | 0.110 |
Why?
|
| RNA, Neoplasm | 2 | 2014 | 749 | 0.110 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 4242 | 0.110 |
Why?
|
| Extracellular Space | 1 | 2015 | 562 | 0.110 |
Why?
|
| Hydroxamic Acids | 1 | 2016 | 481 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 2 | 2017 | 6188 | 0.110 |
Why?
|
| DNA Methylation | 4 | 2015 | 4391 | 0.110 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2013 | 90 | 0.110 |
Why?
|
| Pregnancy | 12 | 2018 | 29868 | 0.110 |
Why?
|
| Chemokine CCL2 | 3 | 2008 | 602 | 0.110 |
Why?
|
| Microsatellite Instability | 1 | 2017 | 716 | 0.110 |
Why?
|
| Pituitary ACTH Hypersecretion | 1 | 2015 | 179 | 0.110 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2018 | 496 | 0.110 |
Why?
|
| Viral Proteins | 2 | 2019 | 1799 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2014 | 126 | 0.110 |
Why?
|
| DNA | 5 | 2024 | 7196 | 0.110 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 3868 | 0.110 |
Why?
|
| Pituitary Gland | 1 | 2015 | 635 | 0.110 |
Why?
|
| Menarche | 1 | 2015 | 532 | 0.100 |
Why?
|
| Transplantation, Heterologous | 3 | 2011 | 2382 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 319 | 0.100 |
Why?
|
| Meiosis | 1 | 2014 | 327 | 0.100 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2015 | 384 | 0.100 |
Why?
|
| Neoplasm Staging | 6 | 2017 | 11116 | 0.100 |
Why?
|
| Capillaries | 2 | 2008 | 756 | 0.100 |
Why?
|
| Parity | 1 | 2015 | 924 | 0.100 |
Why?
|
| Genes, MDR | 1 | 2012 | 36 | 0.100 |
Why?
|
| Allosteric Site | 1 | 2012 | 103 | 0.100 |
Why?
|
| Veratrum Alkaloids | 1 | 2011 | 23 | 0.100 |
Why?
|
| Sirolimus | 2 | 2017 | 1533 | 0.100 |
Why?
|
| Antigens, Ly | 1 | 2013 | 294 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2017 | 1113 | 0.100 |
Why?
|
| Cell Movement | 1 | 2024 | 5200 | 0.100 |
Why?
|
| Gene Expression Regulation | 5 | 2015 | 11874 | 0.100 |
Why?
|
| Cell Lineage | 2 | 2019 | 2554 | 0.100 |
Why?
|
| Azacitidine | 2 | 2010 | 335 | 0.100 |
Why?
|
| Cytomegalovirus | 2 | 2022 | 749 | 0.100 |
Why?
|
| Genetic Fitness | 1 | 2012 | 115 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2013 | 3777 | 0.100 |
Why?
|
| Breast Neoplasms | 2 | 2017 | 20988 | 0.090 |
Why?
|
| Blastocyst | 1 | 2014 | 432 | 0.090 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2016 | 774 | 0.090 |
Why?
|
| Nucleosomes | 1 | 1995 | 487 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 4 | 2019 | 5780 | 0.090 |
Why?
|
| Follicular Atresia | 2 | 2008 | 7 | 0.090 |
Why?
|
| Sheep | 4 | 1999 | 1436 | 0.090 |
Why?
|
| Receptor, Notch1 | 1 | 2014 | 496 | 0.090 |
Why?
|
| BRCA1 Protein | 2 | 2024 | 1149 | 0.090 |
Why?
|
| Interleukin-6 | 3 | 2013 | 3206 | 0.090 |
Why?
|
| beta Catenin | 3 | 2013 | 1039 | 0.090 |
Why?
|
| Enzyme Activation | 4 | 2010 | 3591 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2014 | 4570 | 0.090 |
Why?
|
| Intestinal Neoplasms | 1 | 2013 | 314 | 0.090 |
Why?
|
| Theca Cells | 2 | 2008 | 15 | 0.090 |
Why?
|
| Blotting, Northern | 4 | 2007 | 1545 | 0.090 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 1718 | 0.090 |
Why?
|
| Progestins | 1 | 2012 | 301 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 3 | 2021 | 2812 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1997 | 1404 | 0.090 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2016 | 1333 | 0.090 |
Why?
|
| Receptors, Leptin | 3 | 2006 | 350 | 0.090 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2010 | 103 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 4910 | 0.090 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2014 | 620 | 0.080 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 345 | 0.080 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 737 | 0.080 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2012 | 287 | 0.080 |
Why?
|
| Mucin-4 | 1 | 2009 | 33 | 0.080 |
Why?
|
| Cell Cycle Proteins | 2 | 2019 | 3447 | 0.080 |
Why?
|
| Mutation | 4 | 2014 | 30016 | 0.080 |
Why?
|
| Fertilization in Vitro | 2 | 2014 | 1292 | 0.080 |
Why?
|
| Cell Separation | 2 | 2020 | 1718 | 0.080 |
Why?
|
| Cell Survival | 5 | 2016 | 5780 | 0.080 |
Why?
|
| Ganciclovir | 1 | 2009 | 252 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2013 | 1056 | 0.080 |
Why?
|
| Cryoprotective Agents | 1 | 2009 | 128 | 0.080 |
Why?
|
| Homeostasis | 2 | 2019 | 3321 | 0.080 |
Why?
|
| Cisplatin | 2 | 2015 | 1650 | 0.080 |
Why?
|
| DNA Copy Number Variations | 2 | 2020 | 2020 | 0.080 |
Why?
|
| Models, Biological | 4 | 2020 | 9461 | 0.080 |
Why?
|
| Organ Culture Techniques | 2 | 2019 | 794 | 0.080 |
Why?
|
| Pancreas Transplantation | 1 | 2009 | 197 | 0.080 |
Why?
|
| Luteal Cells | 3 | 2007 | 19 | 0.080 |
Why?
|
| Trans-Activators | 3 | 2010 | 2852 | 0.080 |
Why?
|
| Genes, ras | 1 | 2010 | 654 | 0.070 |
Why?
|
| Immunomodulation | 1 | 2012 | 548 | 0.070 |
Why?
|
| Estrous Cycle | 1 | 2008 | 65 | 0.070 |
Why?
|
| Endothelial Cells | 3 | 2008 | 3548 | 0.070 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 1550 | 0.070 |
Why?
|
| Cell Death | 2 | 2010 | 1677 | 0.070 |
Why?
|
| Scleroderma, Systemic | 1 | 2012 | 344 | 0.070 |
Why?
|
| Oncogenes | 1 | 2013 | 1221 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2009 | 619 | 0.070 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2007 | 133 | 0.070 |
Why?
|
| Pregnancy, Animal | 1 | 2008 | 124 | 0.070 |
Why?
|
| Nervous System | 1 | 2010 | 545 | 0.070 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2008 | 262 | 0.070 |
Why?
|
| DNA, Complementary | 3 | 2003 | 1989 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2008 | 254 | 0.070 |
Why?
|
| Embryo, Nonmammalian | 1 | 2010 | 905 | 0.070 |
Why?
|
| Germ Cells | 2 | 2010 | 634 | 0.070 |
Why?
|
| Homeodomain Proteins | 2 | 2014 | 2413 | 0.070 |
Why?
|
| DNA Fragmentation | 3 | 2002 | 237 | 0.070 |
Why?
|
| Cell Differentiation | 4 | 2019 | 11514 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2019 | 3394 | 0.070 |
Why?
|
| Postpartum Period | 1 | 2013 | 1178 | 0.070 |
Why?
|
| Receptors, Cytokine | 2 | 2004 | 257 | 0.070 |
Why?
|
| Ovum | 1 | 2007 | 187 | 0.070 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2011 | 584 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2015 | 2160 | 0.070 |
Why?
|
| Interferon Regulatory Factor-1 | 2 | 2008 | 68 | 0.070 |
Why?
|
| Genes, MHC Class I | 1 | 2006 | 235 | 0.060 |
Why?
|
| Mesoderm | 1 | 2009 | 674 | 0.060 |
Why?
|
| Models, Animal | 1 | 2012 | 2109 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2008 | 581 | 0.060 |
Why?
|
| Protein Isoforms | 2 | 2010 | 1697 | 0.060 |
Why?
|
| Genetic Markers | 1 | 2012 | 2601 | 0.060 |
Why?
|
| Zebrafish | 2 | 2022 | 3007 | 0.060 |
Why?
|
| Colon | 1 | 2013 | 1791 | 0.060 |
Why?
|
| Colonic Neoplasms | 2 | 2009 | 2533 | 0.060 |
Why?
|
| Muscle, Smooth | 1 | 2009 | 927 | 0.060 |
Why?
|
| Cell Nucleus | 3 | 2023 | 2894 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 2 | 2021 | 9172 | 0.060 |
Why?
|
| Phenotype | 5 | 2020 | 16571 | 0.060 |
Why?
|
| Dietary Fats | 1 | 2012 | 1995 | 0.060 |
Why?
|
| Cloning, Molecular | 2 | 2004 | 4172 | 0.060 |
Why?
|
| Dinucleotide Repeats | 1 | 2004 | 29 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 1810 | 0.060 |
Why?
|
| HeLa Cells | 1 | 2010 | 3087 | 0.060 |
Why?
|
| Testicular Hormones | 1 | 2004 | 188 | 0.060 |
Why?
|
| DNA-Binding Proteins | 6 | 2010 | 9586 | 0.060 |
Why?
|
| Zebrafish Proteins | 1 | 2010 | 1015 | 0.060 |
Why?
|
| Cyclin D1 | 1 | 2006 | 451 | 0.060 |
Why?
|
| Genotype | 3 | 2015 | 12978 | 0.060 |
Why?
|
| Neurogenesis | 1 | 2010 | 862 | 0.060 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2004 | 103 | 0.060 |
Why?
|
| Databases, Genetic | 1 | 2011 | 1742 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2002 | 613 | 0.060 |
Why?
|
| Life Style | 1 | 2015 | 3904 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 1608 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 1894 | 0.060 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2008 | 376 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2010 | 1320 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2007 | 630 | 0.060 |
Why?
|
| Enzyme Inhibitors | 4 | 2002 | 3705 | 0.060 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2013 | 2048 | 0.050 |
Why?
|
| Animals, Congenic | 1 | 2003 | 27 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2010 | 2915 | 0.050 |
Why?
|
| Rad51 Recombinase | 1 | 2024 | 189 | 0.050 |
Why?
|
| Hydrogen Peroxide | 2 | 2023 | 730 | 0.050 |
Why?
|
| Restriction Mapping | 1 | 2004 | 851 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 1884 | 0.050 |
Why?
|
| Base Sequence | 4 | 2005 | 12421 | 0.050 |
Why?
|
| Receptors, Estrogen | 2 | 2009 | 2208 | 0.050 |
Why?
|
| Carcinoma, Papillary | 1 | 2008 | 785 | 0.050 |
Why?
|
| Spain | 1 | 2004 | 487 | 0.050 |
Why?
|
| Embryo Implantation | 1 | 2004 | 270 | 0.050 |
Why?
|
| Fallopian Tubes | 1 | 2023 | 178 | 0.050 |
Why?
|
| Caspase 8 | 1 | 2003 | 190 | 0.050 |
Why?
|
| Aged | 10 | 2017 | 169042 | 0.050 |
Why?
|
| Glutamates | 1 | 2023 | 389 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2005 | 696 | 0.050 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2022 | 109 | 0.050 |
Why?
|
| Wound Healing | 1 | 2013 | 2802 | 0.050 |
Why?
|
| Rats | 4 | 2015 | 23717 | 0.050 |
Why?
|
| Giant Cell Arteritis | 1 | 2006 | 306 | 0.050 |
Why?
|
| Recombinant Proteins | 3 | 2019 | 6520 | 0.050 |
Why?
|
| Rabbits | 3 | 2013 | 4770 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2015 | 5110 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 2063 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2011 | 10073 | 0.050 |
Why?
|
| Proline | 1 | 2023 | 455 | 0.050 |
Why?
|
| Adult | 10 | 2019 | 220969 | 0.050 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2023 | 330 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2008 | 1606 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2010 | 3514 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2002 | 661 | 0.050 |
Why?
|
| Ovulation | 1 | 2002 | 181 | 0.050 |
Why?
|
| Aged, 80 and over | 7 | 2017 | 58894 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2017 | 17878 | 0.050 |
Why?
|
| Cell Line | 4 | 2019 | 15576 | 0.050 |
Why?
|
| Cohort Studies | 6 | 2020 | 41457 | 0.050 |
Why?
|
| Colorectal Neoplasms | 2 | 2013 | 6925 | 0.050 |
Why?
|
| Gene Frequency | 2 | 2006 | 3601 | 0.050 |
Why?
|
| Protein Transport | 2 | 2019 | 1966 | 0.050 |
Why?
|
| STAT3 Transcription Factor | 2 | 2004 | 871 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 1 | 2008 | 1349 | 0.040 |
Why?
|
| Administration, Oral | 3 | 2013 | 4010 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2004 | 1150 | 0.040 |
Why?
|
| Gonanes | 1 | 2000 | 1 | 0.040 |
Why?
|
| Diet | 2 | 2015 | 8048 | 0.040 |
Why?
|
| Aminoglutethimide | 1 | 2000 | 13 | 0.040 |
Why?
|
| Glutathione | 1 | 2003 | 582 | 0.040 |
Why?
|
| DNA Damage | 1 | 2010 | 2446 | 0.040 |
Why?
|
| Pregnancy Proteins | 1 | 2001 | 222 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 4110 | 0.040 |
Why?
|
| Hormone Antagonists | 1 | 2000 | 106 | 0.040 |
Why?
|
| STAT1 Transcription Factor | 1 | 2001 | 340 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 1738 | 0.040 |
Why?
|
| Middle Aged | 11 | 2017 | 220584 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 3608 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 682 | 0.040 |
Why?
|
| Receptors, Endothelin | 1 | 1999 | 56 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2004 | 17629 | 0.040 |
Why?
|
| Radioimmunoassay | 1 | 2000 | 861 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 1670 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 2 | 2014 | 1703 | 0.040 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2024 | 612 | 0.040 |
Why?
|
| NF-kappa B | 2 | 2013 | 2481 | 0.040 |
Why?
|
| Genes, Synthetic | 1 | 2019 | 88 | 0.040 |
Why?
|
| Mifepristone | 1 | 2000 | 151 | 0.040 |
Why?
|
| Aromatase | 1 | 2019 | 147 | 0.040 |
Why?
|
| Peptide Hydrolases | 1 | 2022 | 624 | 0.040 |
Why?
|
| Ascites | 1 | 2020 | 338 | 0.040 |
Why?
|
| Quinazolines | 2 | 2016 | 1371 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 1999 | 452 | 0.040 |
Why?
|
| Prevalence | 1 | 2015 | 15689 | 0.040 |
Why?
|
| Feedback | 1 | 2022 | 790 | 0.040 |
Why?
|
| Fetal Blood | 1 | 2005 | 1347 | 0.040 |
Why?
|
| Random Allocation | 2 | 2013 | 2392 | 0.040 |
Why?
|
| Aging | 2 | 2019 | 8699 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2019 | 360 | 0.040 |
Why?
|
| Autoradiography | 1 | 1999 | 728 | 0.040 |
Why?
|
| RNA Interference | 2 | 2019 | 2830 | 0.040 |
Why?
|
| Matched-Pair Analysis | 1 | 2018 | 284 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2022 | 4571 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2010 | 12447 | 0.040 |
Why?
|
| Ligands | 2 | 2020 | 3268 | 0.040 |
Why?
|
| Receptors, OSM-LIF | 2 | 2008 | 15 | 0.040 |
Why?
|
| Spleen | 1 | 2003 | 2286 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2019 | 658 | 0.030 |
Why?
|
| Time Factors | 2 | 2020 | 39913 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2001 | 557 | 0.030 |
Why?
|
| Concanavalin A | 2 | 2008 | 190 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2009 | 3039 | 0.030 |
Why?
|
| Leukemia Inhibitory Factor | 2 | 2008 | 77 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2003 | 2231 | 0.030 |
Why?
|
| Young Adult | 2 | 2014 | 59179 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 4739 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 2 | 2014 | 596 | 0.030 |
Why?
|
| Heterochromatin | 1 | 2019 | 291 | 0.030 |
Why?
|
| E2F2 Transcription Factor | 1 | 2015 | 35 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 4533 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 801 | 0.030 |
Why?
|
| Caspase 1 | 1 | 1997 | 226 | 0.030 |
Why?
|
| Epithelium | 1 | 2020 | 1603 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 5789 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 1997 | 282 | 0.030 |
Why?
|
| Genes, cdc | 1 | 2015 | 114 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 10754 | 0.030 |
Why?
|
| Epitopes | 1 | 2022 | 2501 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2004 | 1852 | 0.030 |
Why?
|
| Superovulation | 1 | 1995 | 11 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2003 | 2604 | 0.030 |
Why?
|
| Retinoblastoma Protein | 1 | 2019 | 671 | 0.030 |
Why?
|
| Benzoxazoles | 1 | 2016 | 90 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2000 | 1079 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2016 | 384 | 0.030 |
Why?
|
| bcl-X Protein | 1 | 1997 | 410 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2017 | 329 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2002 | 1403 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1995 | 206 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1088 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2005 | 4137 | 0.030 |
Why?
|
| Cycloheximide | 1 | 1995 | 343 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2010 | 7583 | 0.030 |
Why?
|
| Pregnancy Rate | 1 | 2018 | 648 | 0.030 |
Why?
|
| Neoplasms | 1 | 2023 | 22131 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2019 | 1503 | 0.030 |
Why?
|
| Genes, myc | 1 | 2015 | 390 | 0.030 |
Why?
|
| Pregnancy Outcome | 2 | 2018 | 2921 | 0.030 |
Why?
|
| Genes, p53 | 1 | 1997 | 712 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2013 | 1745 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2019 | 1642 | 0.030 |
Why?
|
| Live Birth | 1 | 2018 | 510 | 0.030 |
Why?
|
| Peritoneal Neoplasms | 1 | 2020 | 710 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2013 | 15612 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2007 | 3794 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 1997 | 552 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2009 | 4236 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2015 | 305 | 0.030 |
Why?
|
| Antibodies | 1 | 2022 | 2414 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2010 | 22148 | 0.030 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2013 | 110 | 0.030 |
Why?
|
| Culture Media | 1 | 2015 | 895 | 0.030 |
Why?
|
| Litter Size | 1 | 2012 | 49 | 0.030 |
Why?
|
| Breeding | 1 | 2012 | 51 | 0.030 |
Why?
|
| Promegestone | 1 | 2012 | 9 | 0.030 |
Why?
|
| Up-Regulation | 3 | 2009 | 4117 | 0.030 |
Why?
|
| Phosphorylation | 4 | 2010 | 8311 | 0.030 |
Why?
|
| Chorionic Gonadotropin | 1 | 1995 | 457 | 0.030 |
Why?
|
| Age Factors | 2 | 2007 | 18381 | 0.030 |
Why?
|
| Survival Rate | 2 | 2020 | 12719 | 0.030 |
Why?
|
| Cullin Proteins | 1 | 2013 | 179 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1995 | 2185 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 15908 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2016 | 1755 | 0.020 |
Why?
|
| Soybean Oil | 1 | 2012 | 139 | 0.020 |
Why?
|
| Plant Oils | 1 | 2012 | 198 | 0.020 |
Why?
|
| Cell Division | 1 | 2019 | 4457 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2003 | 3113 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2019 | 2409 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 2202 | 0.020 |
Why?
|
| Massachusetts | 2 | 2018 | 8833 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 1963 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 2191 | 0.020 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2012 | 146 | 0.020 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2012 | 225 | 0.020 |
Why?
|
| Male | 12 | 2013 | 360358 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2013 | 656 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2013 | 577 | 0.020 |
Why?
|
| Infertility | 1 | 2018 | 654 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2011 | 2917 | 0.020 |
Why?
|
| New Hampshire | 1 | 2010 | 175 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2010 | 112 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2013 | 982 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2019 | 2049 | 0.020 |
Why?
|
| Mitochondria | 1 | 2023 | 3619 | 0.020 |
Why?
|
| Phase Transition | 1 | 2009 | 71 | 0.020 |
Why?
|
| Proteomics | 1 | 2023 | 3836 | 0.020 |
Why?
|
| Propylene Glycols | 1 | 2009 | 91 | 0.020 |
Why?
|
| Trehalose | 1 | 2009 | 88 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2013 | 902 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2009 | 351 | 0.020 |
Why?
|
| Mitosis | 1 | 2014 | 1187 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2011 | 370 | 0.020 |
Why?
|
| Placebos | 1 | 2013 | 1667 | 0.020 |
Why?
|
| Fertilization | 1 | 2009 | 198 | 0.020 |
Why?
|
| Proteins | 1 | 2023 | 6030 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2024 | 4642 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2013 | 1674 | 0.020 |
Why?
|
| Uterine Diseases | 1 | 2009 | 108 | 0.020 |
Why?
|
| COS Cells | 1 | 2010 | 1130 | 0.020 |
Why?
|
| Nitrogen | 1 | 2009 | 345 | 0.020 |
Why?
|
| Plant Lectins | 1 | 2008 | 103 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2010 | 557 | 0.020 |
Why?
|
| Transfection | 1 | 2016 | 5766 | 0.020 |
Why?
|
| Egtazic Acid | 1 | 2007 | 167 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2010 | 504 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2010 | 380 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 1118 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2009 | 1759 | 0.020 |
Why?
|
| Chemoprevention | 1 | 2009 | 325 | 0.020 |
Why?
|
| Remission Induction | 1 | 2012 | 2391 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2009 | 506 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 88234 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2008 | 613 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2018 | 54360 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2007 | 332 | 0.020 |
Why?
|
| Embryo Transfer | 1 | 2009 | 522 | 0.020 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2020 | 3164 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2010 | 1202 | 0.020 |
Why?
|
| HLA-B Antigens | 1 | 2006 | 317 | 0.020 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2009 | 384 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 2007 | 820 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 614 | 0.020 |
Why?
|
| Europe | 1 | 2012 | 3413 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 2006 | 602 | 0.010 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2007 | 852 | 0.010 |
Why?
|
| Embryonic Development | 1 | 2009 | 721 | 0.010 |
Why?
|
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2004 | 30 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 2008 | 767 | 0.010 |
Why?
|
| Integrin beta3 | 1 | 2004 | 120 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2020 | 4250 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2016 | 3027 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2012 | 4611 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 2009 | 1182 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2007 | 1463 | 0.010 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2004 | 302 | 0.010 |
Why?
|
| Endothelin-1 | 1 | 2005 | 302 | 0.010 |
Why?
|
| Receptors, Peptide | 1 | 2004 | 279 | 0.010 |
Why?
|
| Hysterectomy | 1 | 2008 | 856 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 1927 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 1755 | 0.010 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 998 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2018 | 64568 | 0.010 |
Why?
|
| Monocytes | 1 | 2012 | 2565 | 0.010 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2004 | 407 | 0.010 |
Why?
|
| Carbocyanines | 1 | 2002 | 175 | 0.010 |
Why?
|
| Endothelium | 1 | 2005 | 764 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 2008 | 1269 | 0.010 |
Why?
|
| Precancerous Conditions | 1 | 2009 | 980 | 0.010 |
Why?
|
| CHO Cells | 1 | 2004 | 1387 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 3680 | 0.010 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2003 | 278 | 0.010 |
Why?
|
| Binding Sites | 1 | 2010 | 6051 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2008 | 80566 | 0.010 |
Why?
|
| Caspase 7 | 1 | 2001 | 50 | 0.010 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 2001 | 41 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2010 | 2241 | 0.010 |
Why?
|
| Cricetinae | 1 | 2004 | 2424 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5672 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2011 | 3431 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2005 | 1336 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 4745 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 2012 | 1580 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2001 | 531 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2001 | 205 | 0.010 |
Why?
|
| Heart | 1 | 2013 | 4403 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2004 | 1248 | 0.010 |
Why?
|
| Homozygote | 1 | 2005 | 1776 | 0.010 |
Why?
|
| Chromones | 1 | 2000 | 148 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2001 | 287 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 6074 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 318 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2006 | 1348 | 0.010 |
Why?
|
| Recurrence | 1 | 2012 | 8426 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2872 | 0.010 |
Why?
|
| Receptor, Endothelin A | 1 | 1999 | 56 | 0.010 |
Why?
|
| Chemokines | 1 | 2003 | 954 | 0.010 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2003 | 517 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 2002 | 642 | 0.010 |
Why?
|
| Macrophages | 1 | 2014 | 5758 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 2817 | 0.010 |
Why?
|
| Renin-Angiotensin System | 1 | 2003 | 737 | 0.010 |
Why?
|
| Androstadienes | 1 | 2000 | 348 | 0.010 |
Why?
|
| Heterozygote | 1 | 2005 | 2780 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2001 | 584 | 0.010 |
Why?
|
| Genome, Human | 1 | 2011 | 4421 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2005 | 1835 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2008 | 6807 | 0.010 |
Why?
|
| Liver | 1 | 2013 | 7512 | 0.010 |
Why?
|
| Flavonoids | 1 | 2001 | 445 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 12043 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2018 | 26180 | 0.010 |
Why?
|
| Comorbidity | 1 | 2012 | 10505 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 10175 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2001 | 1687 | 0.010 |
Why?
|
| Disease Progression | 1 | 2013 | 13495 | 0.010 |
Why?
|
| Logistic Models | 1 | 2010 | 13245 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2001 | 2668 | 0.010 |
Why?
|
| Protein Binding | 1 | 2007 | 9345 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 1901 | 0.010 |
Why?
|
| Inflammation | 1 | 2014 | 10760 | 0.010 |
Why?
|
| Oxygen | 1 | 2005 | 4226 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 20074 | 0.010 |
Why?
|
| Kinetics | 1 | 2000 | 6370 | 0.010 |
Why?
|
| Estradiol | 1 | 1999 | 1937 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 1995 | 963 | 0.010 |
Why?
|
| Incidence | 1 | 2009 | 21337 | 0.010 |
Why?
|
| Swine | 1 | 2000 | 5907 | 0.010 |
Why?
|
| Insulin | 1 | 1999 | 6593 | 0.000 |
Why?
|
| Risk Factors | 1 | 2011 | 74115 | 0.000 |
Why?
|
| Body Mass Index | 1 | 2001 | 12943 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1995 | 13441 | 0.000 |
Why?
|